← Eichor
Condition: Leptomeningeal Disease Lmd Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Leptomeningeal Disease Lmd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated
Phase 2 · 2 location(s) · Sunnybrook Health Sciences Centre · NCT06016387Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
Phase 2 · 1 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT07694986CSF and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and CNS Metastases or no CNS Metastases
NA · 1 location(s) · Sunnybrook Health Sciences Centre · NCT07476781
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.